Leelotus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Leelotus Pharmaceuticals
Leelotus Pharmaceuticals Limited (LPL) is a Public Limited Indian Non-Government Company incorporated in India on 01 May 2017 (Seven years and nine months 27 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rajan Singh, Sanjay Singh, and Shubham serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999HR2017PLC068850
- Company No.
068850
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 May 2017
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Leelotus Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajan Singh  | Director | 01-May-2017 | Current |
| Sanjay Singh | Director | 01-May-2017 | Current |
| Shubham | Director | 14-Jun-2023 | Current |
Financial Performance of Leelotus Pharmaceuticals.
Enhance accessibility to Leelotus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Leelotus Pharmaceuticals?
In 2018, Leelotus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Leelotus Beverage Corporation LimitedRajan Singh, Sanjay Singh and 1 more are mutual person
- Lotusn Dream Projects And Developers Private Limited
Rajan Singh and . Shubham are mutual person
- Lotus Earth Saviours Foundation
Rajan Singh is a mutual person
- Gallantry Construction Private Limited
Sanjay Singh is a mutual person
- Lotusdream Infratech Private Limited
Sanjay Singh is a mutual person
- Lotus City Mart Private Limited
Sanjay Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Leelotus Pharmaceuticals?
Unlock and access historical data on people associated with Leelotus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leelotus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leelotus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
